Gangfeng Xu

3.3k citations
12 papers · 2.7k indexed · 3 hit papers · h-index 8
Topics
Neurofibromatosis and Schwannoma Cases (10 papers)Sarcoma Diagnosis and Treatment (3 papers)Hippo pathway signaling and YAP/TAZ (2 papers)

In The Last Decade

Gangfeng Xu

12 papers receiving 2.6k citations

Hit Papers

The neurofibromatosis type 1 gene encodes a protein relat...1990202620022014199019901990250500750

Peers

Gangfeng Xu
Comparison fields: 5 of 72
  • Neurology 1.7k
  • Molecular Biology 1.0k
  • Epidemiology 494
  • Pulmonary and Respiratory Medicine 482
  • Rheumatology 427
Replace Jeff Stevens with:
Jeff Stevens United States
Lone B. Andersen United States
D. Wade Clapp United States
Lee B. Jacoby United States
Jeffrey E. DeClue United States
M. Josefa Bello Spain
Yuan Zhu Germany
Shyra J. Miller United States
José M. de Campos Spain
Juan A. Rey Spain
Gangfeng Xu relative to Jeff Stevens United States Jeff Stevens's profile →
Citations per field
00.5×1.5×
Jeff Stevens · 1×
Citations per year

Countries citing papers authored by Gangfeng Xu

Since Specialization
Citations

This map shows the geographic impact of Gangfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gangfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gangfeng Xu more than expected).

Fields of papers citing papers by Gangfeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gangfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gangfeng Xu. The network helps show where Gangfeng Xu may publish in the future.

Co-authorship network of co-authors of Gangfeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Gangfeng Xu. A scholar is included among the top collaborators of Gangfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gangfeng Xu. Gangfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 3
2 4
3 7
4 6
5 31
6 11
7 98
8 92
9 78
10
The neurofibromatosis type 1 gene encodes a protein related to GAPbreakdown →
907
11
The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiaebreakdown →
582
12
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locusbreakdown →
850

About Gangfeng Xu

Gangfeng Xu is a scholar working on Neurology, Cell Biology and Biochemistry, having authored 12 papers that have together received 2.7k indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (10 papers), Sarcoma Diagnosis and Treatment (3 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). The work is most often cited by research in Neurology (1.7k citations), Rheumatology (427 citations) and Cell Biology (373 citations). Gangfeng Xu has collaborated with scholars based in United States, China and Malaysia. Frequent co-authors include R. White, P. O’Connell, David Viskochil, Richard Cawthon, Melanie Culver, Robert B. Weiss, R F Gesteland, Diane M. Dunn, Jeff Stevens and John C. Carey. Their work appears in journals such as Cell, Nucleic Acids Research and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026